Atlas FDA

PROPEL MINI SINUS IMPLANT

FDA premarket approval P100044/S001 · decided 2012-09-21

Approval details

PMA number
P100044
Supplement
S001
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
PROPEL MINI SINUS IMPLANT
Generic name
Drug-eluting sinus stent
Applicant
Intersect Ent.
Date received
2012-03-12
Decision date
2012-09-21
Days to decision
193 days
Decision code
APPR
Product code
OWO
Advisory committee
Ear, Nose, Throat
Expedited review
No
Location
Menlo Park, CA
Statement
APPROVAL FOR A SHORTENED VERSION OF THE DRUG-ELUTING SINUS STENT. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME PROPEL MINI SINUS IMPLANT AND IS INDICATED FOR USE IN PATIENTS >= 18 YEARS OF AGE FOLLOWING ETHMOID SINUS SURGERY TO MAINTAIN PATENCY, THEREBY REDUCING THE NEED FOR POST-OPERATIVE INTERVENTION SUCH AS SURGICAL ADHESION LYSIS AND/OR USE OF ORAL STEROIDS. THE PROPEL MINI SINUS IMPLANT SEPARATES MUCOSAL TISSUES, PROVIDES STABILIZATION OF THE MIDDLE TURBINATE, PREVENTS OBS

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
VenSure LightGuide (K212774)Intersect Ent.2022-02-04